뉴스벤징가
Genmab Stock Hits 52-Week High - Here's Why
· 발표
기사 요약
Genmab shares gain as petosemtamab cuts head and neck cancer death risk by 50%, backing William Blair's $8 billion peak sales projections.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Genmab shares gain as petosemtamab cuts head and neck cancer death risk by 50%, backing William Blair's $8 billion peak sales projections.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…